Notch controls the survival of memory CD4+ T cells by regulating glucose uptake
- PMID: 25501905
- DOI: 10.1038/nm.3758
Notch controls the survival of memory CD4+ T cells by regulating glucose uptake
Abstract
CD4+ T cells differentiate into memory T cells that protect the host from subsequent infection. In contrast, autoreactive memory CD4+ T cells harm the body by persisting in the tissues. The underlying pathways controlling the maintenance of memory CD4+ T cells remain undefined. We show here that memory CD4+ T cell survival is impaired in the absence of the Notch signaling protein known as recombination signal binding protein for immunoglobulin κ J region (Rbpj). Treatment of mice with a Notch inhibitor reduced memory CD4+ T cell numbers and prevented the recurrent induction of experimental autoimmune encephalomyelitis. Rbpj-deficient CD4+ memory T cells exhibit reduced glucose uptake due to impaired AKT phosphorylation, resulting in low Glut1 expression. Treating mice with pyruvic acid, which bypasses glucose uptake and supplies the metabolite downstream of glucose uptake, inhibited the decrease of autoimmune memory CD4+ T cells in the absence of Notch signaling, suggesting memory CD4+ T cell survival relies on glucose metabolism. Together, these data define a central role for Notch signaling in maintaining memory CD4+ T cells through the regulation of glucose uptake.
Similar articles
-
Rheumatoid arthritis-associated RBPJ polymorphism alters memory CD4+ T cells.Hum Mol Genet. 2016 Jan 15;25(2):404-17. doi: 10.1093/hmg/ddv474. Epub 2015 Nov 24. Hum Mol Genet. 2016. PMID: 26604133 Free PMC article.
-
Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor.Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5943-8. doi: 10.1073/pnas.0911755107. Epub 2010 Mar 15. Proc Natl Acad Sci U S A. 2010. PMID: 20231432 Free PMC article.
-
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.Cancer Res. 2010 Mar 15;70(6):2476-84. doi: 10.1158/0008-5472.CAN-09-3114. Epub 2010 Mar 2. Cancer Res. 2010. PMID: 20197467
-
Canonical and non-canonical Notch signaling in CD4⁺ T cells.Curr Top Microbiol Immunol. 2012;360:99-114. doi: 10.1007/82_2012_233. Curr Top Microbiol Immunol. 2012. PMID: 22695917 Review.
-
TCR and Notch signaling in CD4 and CD8 T-cell development.Immunol Rev. 2006 Feb;209:274-83. doi: 10.1111/j.0105-2896.2006.00358.x. Immunol Rev. 2006. PMID: 16448548 Review.
Cited by
-
CD4+ Memory T Cells at Home in the Tissue: Mechanisms for Health and Disease.Front Immunol. 2018 Oct 16;9:2394. doi: 10.3389/fimmu.2018.02394. eCollection 2018. Front Immunol. 2018. PMID: 30386342 Free PMC article. Review.
-
Systemic Expression of Notch Ligand Delta-Like 4 during Mycobacterial Infection Alters the T Cell Immune Response.Front Immunol. 2016 Nov 24;7:527. doi: 10.3389/fimmu.2016.00527. eCollection 2016. Front Immunol. 2016. PMID: 27933064 Free PMC article.
-
MicroRNA-449a deficiency promotes colon carcinogenesis.Sci Rep. 2017 Sep 6;7(1):10696. doi: 10.1038/s41598-017-10500-0. Sci Rep. 2017. PMID: 28878284 Free PMC article.
-
Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17-Dependent Protection against Mycobacterium tuberculosis Infection.J Immunol. 2022 Jan 15;208(2):407-419. doi: 10.4049/jimmunol.2100029. Epub 2021 Dec 29. J Immunol. 2022. PMID: 34965963 Free PMC article.
-
Survivin promotes a glycolytic switch in CD4+ T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis.iScience. 2022 Nov 7;25(12):105526. doi: 10.1016/j.isci.2022.105526. eCollection 2022 Dec 22. iScience. 2022. PMID: 36425763 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous